Objective

To identify

Principal Investigator Bouvier Michel

Competitive Advantages

Biosensors (APJ) from june 2016 to oct. 2016) End Oct .2016

BMS_Undisclosed target – Biosensors – Development of a GPCR-3 small molecule antagonist for cardiovascular indications (PAR4 follow up) – Activity 3.1 (GPCR-3) (from oct 2017 to …)